Works matching IS 2574173X AND DT 2021 AND VI 41 AND IP 3

Results: 18

Switching from blonanserin tablets to blonanserin transdermal patches improves tardive dyskinesia: A case report.

Published in:

Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 440, doi. 10.1002/npr2.12200

By:

Sakai, Shintaro;
Morimoto, Yoshiro;
Matsuzaka, Yusuke;
Nakano, Takeshi;
Kanegae, Shinji;
Imamura, Akira;
Ozawa, Hiroki

Publication type:

Article

Resolvin D2 attenuates chronic pain–induced depression‐like behavior in mice.

Published in:

Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 426, doi. 10.1002/npr2.12198

By:

Suzuki, Hiroe;
Hitora‐Imamura, Natsuko;
Deyama, Satoshi;
Minami, Masabumi

Publication type:

Article

The dopamine D2 agonist quinpirole impairs frontal mismatch responses to sound frequency deviations in freely moving rats.

Published in:

Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 405, doi. 10.1002/npr2.12199

By:

Inaba, Hiroyoshi;
Namba, Hisaaki;
Kida, Satoshi;
Nawa, Hiroyuki

Publication type:

Article

Contributions of HFE polymorphisms to brain and blood iron load, and their links to cognitive and motor function in healthy adults.

Published in:

Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 393, doi. 10.1002/npr2.12197

By:

Kalpouzos, Grégoria;
Mangialasche, Francesca;
Falahati, Farshad;
Laukka, Erika J;
Papenberg, Goran

Publication type:

Article

Transient glyphosate encephalopathy due to a suicide attempt.

Published in:

Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 444, doi. 10.1002/npr2.12201

By:

Yokoyama, Saaya;
Sugisaki, Tomomi;
Ryota, Yoshida;
Yoshiteru, Sato;
Okayasu, Hiroaki;
Shioda, Mukuto;
Suzuki, Keisuke;
Yasui‐Furukori, Norio;
Shimoda, Kazutaka

Publication type:

Article

Neuropharmacology of Antiseizure Drugs.

Published in:: Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 336, doi. 10.1002/npr2.12196
Publication type:: Article

Outcomes of patients with schizophrenia who discontinued long‐acting injectable antipsychotic therapy due to adverse events: A chart review.

Published in:

Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 422, doi. 10.1002/npr2.12192

By:

Kishi, Taro;
Sakuma, Kenji;
Okuya, Makoto;
Hatano, Masakazu;
Iwata, Nakao

Publication type:

Article

SSRIs: Applications in inflammatory lung disease and implications for COVID‐19.

Published in:

Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 325, doi. 10.1002/npr2.12194

By:

Meikle, Claire Kyung Sun;
Creeden, Justin Fortune;
McCullumsmith, Cheryl;
Worth, Randall G.

Publication type:

Article

Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of Schizophrenia".

Published in:: Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 266, doi. 10.1002/npr2.12193
Publication type:: Article

Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.

Published in:

Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 434, doi. 10.1002/npr2.12195

By:

Ishikawa, Hayahito;
Takeshima, Masahiro;
Ishikawa, Hiroyasu;
Ayabe, Naoko;
Ohta, Hidenobu;
Mishima, Kazuo

Publication type:

Article

Medications for attention‐deficit/hyperactivity disorder in Japan: A retrospective cohort study of label compliance.

Published in:

Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 385, doi. 10.1002/npr2.12191

By:

Fife, Daniel;
Voss, Erica A.;
Hardin, Jill;
Rofael, Hany;
Solomon, Ira D.;
Ryan, Patrick B.;
Stang, Paul

Publication type:

Article

Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels.

Published in:

Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 379, doi. 10.1002/npr2.12190

By:

Tasaki, Minami;
Yasui‐Furukori, Norio;
Yokoyama, Saaya;
Shinozaki, Masataka;
Sugawara, Norio;
Shimoda, Kazutaka

Publication type:

Article

Pulverizing medication as a harm reduction and intentional drug overdose prevention strategy: Two case studies.

Published in:

Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 430, doi. 10.1002/npr2.12189

By:

Takanobu, Keisuke;
Okazaki, Daisuke;
Watanabe, Shinya;
Mitsui, Nobuyuki;
Tanaka, Teruaki

Publication type:

Article

Effects of extended abstinence on cognitive functions in tramadol‐dependent patients: A cohort study.

Published in:

Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 371, doi. 10.1002/npr2.12188

By:

Hassaan, Shehab H.;
Khalifa, Hossam;
Darwish, Alaa M.

Publication type:

Article

An initial analysis of the UK Medical Cannabis Registry: Outcomes analysis of first 129 patients.

Published in:

Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 362, doi. 10.1002/npr2.12183

By:

Erridge, Simon;
Salazar, Oliver;
Kawka, Michal;
Holvey, Carl;
Coomber, Ross;
Usmani, Azfer;
Sajad, Mohammed;
Beri, Sushil;
Hoare, Jonathan;
Khan, Shaheen;
Weatherall, Mark W.;
Platt, Michael;
Rucker, James J.;
Sodergren, Mikael H.

Publication type:

Article

Factors associated with the level of prolactin in patients under remission from Alcohol Use Disorder: A gender perspective.

Published in:

Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 352, doi. 10.1002/npr2.12182

By:

Pandey, Susmita;
Bolstad, Ingeborg;
Lien, Lars;
Bramness, Jørgen G.

Publication type:

Article

Inter‐breeder differences in prepulse inhibition deficits of C57BL/6J mice in a maternal immune activation model.

Published in:

Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 416, doi. 10.1002/npr2.12178

By:

Kobayashi, Yutaro;
Inaba, Hiroyoshi;
Iwakura, Yuriko;
Namba, Hisaaki;
Sotoyama, Hidekazu;
Murata, Yui;
Iwamoto, Kazuya;
Nawa, Hiroyuki

Publication type:

Article

Issue Information.

Published in:: Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 265, doi. 10.1002/npr2.12115
Publication type:: Article